Rescheduling could foster marijuana acceptance from health care industry
Moving marijuana from Schedule 1 to Schedule 3 under the Controlled Substances Act could influence whether and how doctors recommend medical cannabis.
Moving marijuana from Schedule 1 to Schedule 3 under the Controlled Substances Act could influence whether and how doctors recommend medical cannabis.
If marijuana is moved from Schedule 1 to Schedule 3 of the Controlled Substances Act, that would expand both access and product selection for medical marijuana patients. But rescheduling likely wouldn’t impact how state-regulated MMJ dispensaries operate.
Some cannabis executives are hopeful that if the federal government moves marijuana from Schedule 1 to 3 of the Controlled Substances Act, then transporting MJ products across state lines will be allowed.
The main investor in a cannabis company licensed by the U.S. Drug Enforcement Administration says the company is “still operating” and recently renewed its agreement with the DEA.
Eli Harrington is among the marijuana farmers tapping into Vermont’s value-added spirit by offering farm tours, events and a gift shop.
When Massachusetts-based multistate operator MariMed decided to launch a delivery service in its home state two years ago, company executives started studying other cannabis carrier services to become experts on the subject.
Licensed marijuana farms are tapping into accommodation-platform opportunities as cultivators battle low flower prices, high taxes.
Curio Wellness built diversification into its business model to provide backup revenue for the company and to overcome marijuana stigmas.
Conventional wisdom contends that businesses and labor unions are naturally adversarial. But it doesn’t have to be that way.
A marijuana company’s payroll provider should focus on cannabis and not also serve mainstream businesses, MJ executives agree.
For evidence of headwinds facing the regulated marijuana industry, look no further than the cannabis labor market.
As marijuana consumers develop a better understanding and appreciation for terpenes, flavonoids and other chemical compounds found in cannabis flower, live resin products are becoming increasingly popular.